A Phase II Study of CHOEP Induction Followed by Gemcitabine/Busulfan/Melphalan Autologous Stem Cell Transplantation for Patients With Newly Diagnosed T-Cell Lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Cyclophosphamide; Doxorubicin; Etoposide; Etoposide; Filgrastim; Gemcitabine; Melphalan; Palifermin; Plerixafor; Prednisone; Vincristine
- Indications T-cell lymphoma
- Focus Therapeutic Use
- 24 Feb 2017 Biomarkers information updated
- 26 Feb 2013 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.